Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

SHILPA MEDICARE LTD. - 530549 - Reg. 34 (1) Annual Report.

 Please find enclosed Notice convening the 35th Annual General Meeting (AGM) of the Company and Annual Report for the financial year 2021-2022 scheduled to be held on Wednesday, the 28th day of September 2022 at 11.30 A.M. IST at the Registered office of the Company through Video Conferencing ('VC') / Other Audio-Visual Means ('OAVM'), in accordance with the relevant circulars issued by the Ministry of Corporate Affairs and the Securities Exchange Board of India.
05-09-2022
Bigul

SHILPA MEDICARE LTD. - 530549 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

 In furtherance to our intimation dated 23 August 2022 & 25 August 2022 with regard to the Q1 FY23 Conference Call held on Wednesday, August 24, 2022 at 03:45 PM IST, please find the enclosed transcript of the call.
30-08-2022
Bigul

SHILPA MEDICARE LTD. - 530549 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

 Pursuant to Regulation 30(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and further to our letter dated August 23, 2022, please note that the audio recording of the conference call for Investors/Analysts for the discussion on Q1 FY23 results, held on August 24, 2022, at 3.45 PM (IST), has been uploaded on our website on the following web link: https://www.vbshilpa.com/investor-presentation.php
25-08-2022
Bigul

SHILPA MEDICARE LTD. - 530549 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to Regulation 30(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the schedule of Q1 FY23 Conference Call to be held on Wednesday, August 24, 2022 at 03:45 PM IST.
23-08-2022
Bigul

SHILPA MEDICARE LTD. - 530549 - Shilpa Medicare Limited Completes Human Clinical Studies Of High Concentration Biosimilar Adalimumab

 This is to inform you that the Company, via its wholly owned subsidiary, Shilpa Biologicals Pvt Ltd (SBPL), has successfully completed the phase 3 Human Clinical studies of its first biosimilar, the 100mg/ml High Concentration (HC) Adalimumab biosimilar and has submitted the dossier to the CDSCO for review and grant of marketing/manufacturing license - a first in India.
19-08-2022
Bigul

SHILPA MEDICARE LTD. - 530549 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Newspaper Publication of Un-audited Standalone and Consolidated Financial Results for the Quarter ended 30th June, 2022 published in compliance with Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 in Soodhimool (Kannada) and Business Line (English) on 13th August 2022
13-08-2022
Bigul

SHILPA MEDICARE LTD. - 530549 - Announcement under Regulation 30 (LODR)-Change in Directorate

 Appointment of Dr. Anita Bandyopadhyay (DIN No: 08672071), as an Additional Women Independent Director of the Company to hold office upto the date of ensuing Annual General Meeting and recommending her appointment as a Women Independent Director for a period of 3 years subject to members approval in the ensuing Annual General Meeting.
12-08-2022
Bigul

SHILPA MEDICARE LTD. - 530549 - Annual General Meeting' Of The Members Of The Company

 This is to inform that the 35' Annual General Meeting (AGM) of the Members of the Company will be held on Wednesday, the 28" September 2022 at 11.30. a.m. IST through Video Conferencing (VC) / Other Audio-Visual Means (OAVM) in accordance with the relevant circulars issued by the Ministry of Corporate Affairs and the Securities and Exchange Board of India.
12-08-2022
Bigul

SHILPA MEDICARE LTD. - 530549 - Announcement under Regulation 30 (LODR)-Investor Presentation

 With reference to the captioned subject, the Investor Presentation of the Company for the Quarter ended 30 June 2022 with regard to Business highlights, financial performance and other updates is attached herewith for your consideration.
12-08-2022
Bigul

SHILPA MEDICARE LTD. - 530549 - Board Meeting Outcome- Financial Results

 This is to intimate that the Board of Directors in its meeting held on 11th August 2022 which commenced at 02.30 p.m. and concluded at 6: 30 p.m. have inter alia considered and approved Un-Audited Financial Results (Standalone and Consolidated) for the quarter ended 30 June 2022.
11-08-2022
Next Page
Close

Let's Open Free Demat Account